DK1888613T3 - Fremgangsmåde til fremstilling af thiophenglycosidderivater - Google Patents

Fremgangsmåde til fremstilling af thiophenglycosidderivater

Info

Publication number
DK1888613T3
DK1888613T3 DK05818005T DK05818005T DK1888613T3 DK 1888613 T3 DK1888613 T3 DK 1888613T3 DK 05818005 T DK05818005 T DK 05818005T DK 05818005 T DK05818005 T DK 05818005T DK 1888613 T3 DK1888613 T3 DK 1888613T3
Authority
DK
Denmark
Prior art keywords
thiophenglycoside
derivatives
preparation
thiophenglycoside derivatives
Prior art date
Application number
DK05818005T
Other languages
English (en)
Inventor
Volker Derdau
Lars Bierer
Michael Kossenjans
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of DK1888613T3 publication Critical patent/DK1888613T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK05818005T 2004-12-22 2005-12-08 Fremgangsmåde til fremstilling af thiophenglycosidderivater DK1888613T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004063099A DE102004063099B4 (de) 2004-12-22 2004-12-22 Verfahren zur Herstellung von Thiophenglycosidderivaten
PCT/EP2005/013158 WO2006072334A2 (de) 2004-12-22 2005-12-08 Verfahren zur herstellung von thiophenglycosidderivaten

Publications (1)

Publication Number Publication Date
DK1888613T3 true DK1888613T3 (da) 2009-03-30

Family

ID=36599271

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05818005T DK1888613T3 (da) 2004-12-22 2005-12-08 Fremgangsmåde til fremstilling af thiophenglycosidderivater

Country Status (29)

Country Link
US (1) US20080207882A1 (da)
EP (1) EP1888613B1 (da)
JP (1) JP2008524272A (da)
KR (1) KR20070089946A (da)
CN (1) CN101080416A (da)
AR (1) AR052272A1 (da)
AT (1) ATE415407T1 (da)
AU (1) AU2005324187A1 (da)
BR (1) BRPI0519438A2 (da)
CA (1) CA2591114A1 (da)
CL (1) CL2008002563A1 (da)
CY (1) CY1108819T1 (da)
DE (2) DE102004063099B4 (da)
DK (1) DK1888613T3 (da)
ES (1) ES2318574T3 (da)
HR (1) HRP20090105T3 (da)
IL (1) IL183806A0 (da)
MA (1) MA29111B1 (da)
NO (1) NO20073213L (da)
NZ (1) NZ555591A (da)
PL (1) PL1888613T3 (da)
PT (1) PT1888613E (da)
RS (1) RS50726B (da)
RU (1) RU2394835C2 (da)
SI (1) SI1888613T1 (da)
TW (1) TW200635940A (da)
UY (1) UY29306A1 (da)
WO (1) WO2006072334A2 (da)
ZA (1) ZA200704028B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20090938A1 (es) 2007-08-16 2009-08-08 Boehringer Ingelheim Int Composicion farmaceutica que comprende un derivado de benceno sustituido con glucopiranosilo
WO2010092125A1 (en) 2009-02-13 2010-08-19 Boehringer Ingelheim International Gmbh Pharmaceutical composition comprising a sglt2 inhibitor, a dpp-iv inhibitor and optionally a further antidiabetic agent and uses thereof
UY33937A (es) 2011-03-07 2012-09-28 Boehringer Ingelheim Int Composiciones farmacéuticas que contienen inhibidores de dpp-4 y/o sglt-2 y metformina
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10231370B4 (de) * 2002-07-11 2006-04-06 Sanofi-Aventis Deutschland Gmbh Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel

Also Published As

Publication number Publication date
DE102004063099A1 (de) 2006-07-13
RU2007127840A (ru) 2009-01-27
WO2006072334A3 (de) 2007-06-07
AR052272A1 (es) 2007-03-07
IL183806A0 (en) 2007-10-31
PL1888613T3 (pl) 2009-04-30
TW200635940A (en) 2006-10-16
BRPI0519438A2 (pt) 2009-01-20
CY1108819T1 (el) 2014-04-09
JP2008524272A (ja) 2008-07-10
KR20070089946A (ko) 2007-09-04
DE502005006107D1 (de) 2009-01-08
PT1888613E (pt) 2009-01-30
RS50726B (sr) 2010-08-31
HRP20090105T3 (en) 2009-03-31
SI1888613T1 (sl) 2009-04-30
WO2006072334A2 (de) 2006-07-13
NZ555591A (en) 2009-07-31
ZA200704028B (en) 2008-08-27
DE102004063099B4 (de) 2009-02-12
AU2005324187A1 (en) 2006-07-13
ES2318574T3 (es) 2009-05-01
CL2008002563A1 (es) 2009-01-02
EP1888613A2 (de) 2008-02-20
RU2394835C2 (ru) 2010-07-20
ATE415407T1 (de) 2008-12-15
CA2591114A1 (en) 2006-07-13
NO20073213L (no) 2007-09-19
MA29111B1 (fr) 2007-12-03
US20080207882A1 (en) 2008-08-28
EP1888613B1 (de) 2008-11-26
CN101080416A (zh) 2007-11-28
UY29306A1 (es) 2006-07-31

Similar Documents

Publication Publication Date Title
DK1828164T3 (da) Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider
DK1778668T3 (da) Fremgangsmåde til fremstilling af dihydropteridion
DK1981863T3 (da) Fremgangsmåde til fremstilling af aminocrotonylaminosubtituerede quinazolinderivater
DK1813678T3 (da) Fremgangsmåde til fremstilling af glycogen
DK1893586T3 (da) Fremgangsmåde til fremstilling af 1-alkyl-3-phenyluraciler
DK2431359T3 (da) Fremgangsmåde til fremstilling af diaminophenothiaziniumforbindelser
DK2086944T3 (da) Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater
DK1756049T3 (da) Fremgangsmåde til fremstilling af 1,4-diphenylazetidinon-derivater
DK1802579T3 (da) Derivater af 3-arylaminopyridin
DK2094676T3 (da) Ny fremgangsmåde til fremstillingen af 2-iminothiazolidin-4-on-derivater
DK1858342T3 (da) Fremgangsmåde til fremstilling af ernæringssammensætninger
DK1737461T3 (da) Carbolin-derivater til inhibering af angiogenese
DK1637610T3 (da) Fremgangsmåde til fremstilling af alkylestere
DK1711481T3 (da) Fremgangsmåde til fremstilling af 2-aminothiazol-5-aromatiske carboxamider som kinaseinhibitorer
DK1928503T3 (da) Fremgangsmåde til fremstilling af oprensede lægemiddelkonjugater
DK2402005T3 (da) Formuleringer med langvarig frigivelse af nalbuphin
DK1884507T3 (da) Fremgangsmåde til fremstilling af glycerol
DK2213654T3 (da) Fremgangsmåde til fremstilling af 2-amino-5-brombenzamid derivater
DK1831223T3 (da) Fremgangsmåde til fremstilling af L-biopterin
DK1963251T3 (da) Fremgangsmåde til fremstilling af aminer
DK1667967T3 (da) Fremgangsmåde til fremstilling af 2-oxo-1-pyrrolidin-derivater
DK1727782T3 (da) Fremgangsmåde til fremstilling af aminophenolforbindelser
DK1838683T3 (da) Fremgangsmåde til fremstilling af [1,4,5]-oxadiazepinderivater
DK1805316T3 (da) Fremgangsmåde til fremstilling af de enantiomere former af cis-3-hydroxycy-
DK1794111T3 (da) Fremgangsmåde til fremstilling af cyclopentanon